Abstract
The rise of antibiotic resistance poses a significant and ongoing challenge to public health, with pathogenic bacteria remaining a persistent threat. Traditional culture methods, while considered the gold standard for bacterial detection and viability assessment, are time-consuming and labor-intensive. To address this limitation, we developed a novel point-of-care (POC) detection method leveraging citrate- and alkyne-modified gold nanorods (AuNRs) synthesized with click chemistry properties. These AuNRs exhibit superior biocompatibility and enhanced quantitative performance compared to conventional surfactant-modified AuNRs. Our method, termed AuNRs–bacteria-initiated click chemistry (AuNRs–BICC), detects CuII-reducing bacteria by quantifying AuNRs bound to a biosensing interface via bacteria-mediated CuII reduction to CuI and subsequent click chemistry with biosensing interface of azide modifications. Using dark-field microscopy (DFM), we demonstrated a strong linear correlation between AuNR counts and the logarithm of bacterial concentration for both Gram-negative Escherichia coli (including KPC-2-expressing antibiotic-resistant strains) and Gram-positive Staphylococcus aureus across a range of 101 to 107 cells, achieving a remarkable detection limit of 101 cells. The AuNRs–BICC biosensor exhibits high selectivity for target bacterial strains and provides rapid detection within 3 h. Furthermore, it can assess bacterial viability in the presence of various antibiotics, including meropenem, ceftriaxone and tetracycline, suggesting its potential for rapid antibiotic susceptibility testing and facilitating timely clinical intervention for infectious diseases.
Keywords: Gold nanorods, Click chemistry, Microbial sensor, Biomarker, POCT
Graphical abstract
Highlights
-
•
A POC microbial sensor via single-particles enumeration under dark-field microscopy was developed.
-
•
This sensor can be utilized for bacterial quantification, viability assessment and antimicrobial susceptibility testing.
-
•
Compared to traditional methods, this sensor demonstrates great potential for clinical POC diagnosis of bacterial infections.
1. Introduction
Pathogenic bacteria represent a significant threat to public health, causing a wide range of human diseases. The relatively low infectious dose required by many bacterial species, coupled with the alarming rise of antimicrobial resistance (estimated to have contributed to 4.95 million deaths in 2019 [[1], [2], [3]]), exacerbates this challenge. Common bacterial infections encompass foodborne illnesses, urinary tract infections, sexually transmitted infections, and healthcare-associated infections [4,5]. The substantial economic burden associated with these infections, along with the widespread prevalence of antibiotic resistance, underscores the urgent need for rapid and reliable point-of-care diagnostic assays for bacterial identification and antimicrobial susceptibility testing (AST).
Traditional culture-based methods for bacterial detection, while considered the gold standard, are time-consuming and labor-intensive. This has spurred the development of alternative strategies, including polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (advantages, disadvantages, and applications summarized in Table S1) [[6], [7], [8], [9]]. However, these methods often require specialized equipment and trained personnel, hindering their widespread implementation, particularly in resource-limited settings [[10], [11], [12], [13]]. Recent research has highlighted bacterial adaptation mechanisms to copper-rich environments, involving copper-binding systems and reductases [[14], [15], [16], [17], [18], [19], [20], [21]]. This copper-related pathway has inspired the development of novel biosensing strategies. Click chemistry, particularly the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction [22,23], offers highly efficient and selective chemical reactions with minimal byproducts, ideal for biological applications. Building upon this, colorimetric assays employing bacteria-instructed click chemistry with gold nanoparticles (AuNPs) and electrochemically mediated atom transfer radical polymerization have shown promise for bacterial detection [14,[24], [25], [26]]. Nevertheless, these assays suffer from limitations, including susceptibility to environmental interference, low sensitivity, and the need for calibration, which hinder accurate quantification and drug resistance evaluation.
Gold nanorods (AuNRs) are promising nanomaterials for various applications due to their unique optical properties (plasmonics), tunable resonance frequency dependent on their aspect ratio, and facile synthesis [[27], [28], [29]]. However, traditional surfactant-modified AuNRs suffer from cytotoxicity and poor biocompatibility, limiting their use in biological systems [27]. Recent advances in citrate-capped AuNRs have addressed these limitations, paving the way for their use in a variety of bio-applications [30,31]. Single-particle enumeration using DFM has emerged as a powerful technique for analyzing metallic nanocrystals, such as gold nanoparticles (AuNPs), offering high sensitivity and the ability to analyze individual particles based on their strong plasmon scattering [32]. To our knowledge, the application of citrate-capped AuNRs and DFM imaging for sensitive, portable, and cost-effective bacterial quantification and drug resistance evaluation using copper-catalyzed azide-alkyne cycloaddition (CuAAC) remains unexplored.
Here, we present a novel point-of-care (POC) bacterial detection method, termed AuNRs–BICC, employing newly synthesized citrate- and alkyne-modified AuNRs with enhanced scattering properties, click chemistry functionality, and excellent biocompatibility. This method leverages AuNR enumeration and DFM imaging. To mitigate non-specific binding on the coverslip surface, we optimized surface treatment using a PLL–PEG–azide polymer, effectively minimizing background signals and non-specific physisorption, consistent with previous reports [[33], [34], [35], [36], [37], [38]]. To ensure assay stability, reactions were performed at a constant temperature to prevent nanoparticle aggregation or dispersion, and pH was controlled using a buffer solution to maintain surface charge stability. The AuNRs–BICC assay relies on the bacterial reduction of exogenous CuII to CuI, which subsequently catalyzes the CuAAC reaction, leading to AuNR immobilization on the coverslip surface and enabling bacterial quantification via DFM (illustrated in Fig. 2). This AuNRs–BICC sensor demonstrates high selectivity for specific bacterial strains, enabling their detection in complex samples. Furthermore, the platform's adaptability extends to antibiotic susceptibility testing.
Fig. 2.
Conceptual illustration of the bacteria-initiated click chemistry for POC microbial detection. (A) Depicts relevant copper homeostasis mechanisms in E. coli and the copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. Specifically, CopA (CuI-translocating P-type ATPase), Ndh-2 (cupric reductase), and CusCBA (copper efflux pump) [45]. (B), (C), and (D) present schematic representations and DFM images within the microreactor for three scenarios: (B) absence of bacteria, (C) presence of bacteria, and (D) presence of both bacteria and antibiotics.
2. Material and methods
2.1. Materials
Tetrachloroauric(III) acid tetrahydrate (HAuCl4⋅4H2O), hexadecyltrimethylammonium bromide (CTAB), hydroquinone, sodium borohydride (NaBH4), potassium hydroxide (KOH) and silver nitrate (AgNO3) were purchased from Sinopharm Chemical Reagent Co, Ltd. (Shanghai, China). Meropenem was purchased from Shanghai Yuanye Biotechnology Co., Ltd. (Shanghai, China). Levofloxacin was from Shanghai Macklin Biochemical Co., Ltd. (Shanghai, China). Ceftriaxone disodium salt hemiheptahydrate and tetracycline hydrochloride were from J&K Scientific (Shanghai, China). N-(3-(Dimethylamino)propyl-N′-ethylcarbodiimide)hydrochloride (EDC), N-hydroxysulfosuccinimide sodium salt (NHS), Tris-(2-carboxyethyl)-phosphine hydrochloride (TCEP), copper(II) chloride (CuCl2), DNase I (Deoxyribonuclease I), Sodium polystyrenesulfonate (Na-PSS, Mw = 70 kDa) and sodium ascorbate were purchased from Sigma-Aldrich (Shanghai, China). Poly(L-lysine)-poly(ethyleneglycol)-azide (PLL-PEG-azide, PLL(3 kDa)-PEG(5 kDa)-azide) and Poly(L-lysine)-poly(ethyleneglycol) (PLL-PEG, PLL(3 kDa)-PEG(4.6 kDa)) were obtained from NanosoftPolymers (NorthCarolina, USA). Carboxyl-modified magnetic beads (COOH-MBs, 10 mg/mL) were purchased from Invitrogen (California, USA). Streptavidin-modified magnetic beads (SA-MBs, 10 mg/mL) were purchased from MedChemExpress (New Jersey, USA). Luria-Bertani broth medium (LB) and Tryptone Soy Agar (TSA) were from Beijing Land Bridge Technology Co., Ltd. (Beijing, China). All chemicals and reagents were analytical grade or higher, and used as received without further purification. Escherichia coli (E. coli, ATCC 25922) and Staphylococcus aureus (S. aureus, ATCC 25923) were obtained from Bioyong Technologics Inc (Beijing, China). All oligonucleotides (the sequences of oligonucleotides were described in Table S2) were synthesized by Sangon Biotech (Shanghai, China). The Flexdym film (thickness of 2 mm) was procured from Eden Tech Featured Inc. (Paris, France). Deionized (DI) water (Millipore Milli-Q grade, 18.2 MΩ) was used in all the experiments.
2.2. Apparatus
The UV–vis absorption spectrum of the colloidal AuNR solution was acquired using an Agilent HP8453 UV–vis spectrophotometer. AuNR morphology and dimensions were characterized using a JEOL JEM-2011 transmission electron microscope (TEM) operating at 200 kV. Zeta (ζ) potential and AuNR size measurements were conducted using a Malvern Zetasizer Nano ZS (ZS90-2027). All dark-field images were acquired using a 100 × Leica dark-field condenser coupled to a dark-field microspectroscopy imaging system equipped with a true-color CCD camera.
2.3. Synthesis of the citrate-capped AuNRs
Citrate-capped AuNRs were synthesized using a seed-mediated method [39] followed by a poly(4-styrenesulfonic acid) (PSS)-mediated ligand exchange [40]. Briefly, cetyltrimethylammonium bromide (CTAB)-capped AuNRs were synthesized and purified via three centrifugation and redispersion (C/R) cycles in 0.15 wt% Na-PSS to remove CTAB. Subsequently, the resulting PSS-coated AuNRs underwent two additional C/R cycles in 2 mM sodium citrate to replace PSS with citrate, yielding stable citrate-capped AuNR sols.
2.4. Preparation of sample chambers and azide functionalization of the coverslip surface (azide–functionalized coverslip)
Sterile, enclosed sample chambers were fabricated by bonding a Flexdym coverslip containing 5 mm diameter holes to a glass coverslip. The coverslip surface was then modified with PEG using a method adapted from a previous report [41]. Briefly, the sample chambers were etched with vacuum plasma for 10 min (PDC-002, Harrick Plasma Inc., USA). A 30 μL mixture of PLL-PEG and PLL-PEG-azide (1 mg/mL each, 1:1 ratio) was then introduced into each chamber and incubated for 1 h. Following incubation, the modified chambers were washed with PBS (20 mM phosphate, 120 mM NaCl, pH 7.4) to remove excess PEG. Finally, a second Flexdym coverslip with a single injection micro-hole was placed onto the modified coverslip, creating a sealed and sterile reactor.
2.5. Formation of alkyne-modified dsDNA assembly on AuNRs
AuNRs were functionalized with alkyne-modified thiolated DNA (alkyne–DNA–SH) via Au–S bond formation. First, alkyne–DNA–SH (3 μL, 100 μM) was reduced with TCEP (3 μL, 5 mM) in 100 mM Tris-HCl (pH 7.0) at 25 °C for 1 h. This solution was then added to 1 mL of AuNR solution (1 mg/mL) and incubated at 4 °C for 24 h. Excess reagents and unbound DNA were removed by centrifugation at 7000 rpm for 10 min, followed by resuspension of the AuNR pellet in 1 mL of deionized (DI) water. To form the double-stranded DNA (dsDNA)–AuNR conjugate, complementary DNA (cDNA) (100 μM) was added to the alkyne–DNA–functionalized AuNRs. The mixture was heated to 95 °C for 10 min and then slowly cooled to room temperature (25 °C). Finally, unreacted cDNA was removed by centrifugation at 7000 rpm for 10 min.
2.6. Bacteria-instructed click chemistry between the azide–functionalized coverslip and alkyne–modified AuNRs
The bacterial detection assay was initiated by mixing CuCl2 (10 μL, 10 μM) with varying concentrations of bacteria (10 μL, ranging from 0 to 108 cells in total) and incubating for 10 min. This allowed for bacterial reduction of CuII to CuI. Next, alkyne-modified AuNRs (10 μL, 1 mg/mL) were added to the mixture, and the combined solution was introduced onto azide-functionalized coverslips. The reaction was allowed to proceed at 37 °C for 2 h. The bacteria-initiated click chemistry reaction was then quenched by removing the reaction mixture, followed by three washes with PBS. Finally, the number of immobilized AuNRs was quantified using DFM.
2.7. Bacterial capture and isolation using aptamer-based magnetic separation
The synthesis of streptavidin-modified magnetic beads conjugated with biotinylated aptamers (SA–MBs–aptamers) and carboxyl-modified magnetic beads conjugated with amine-modified aptamers (COOH–MBs–aptamers) is described in the Supplementary Material. Briefly, 1 mL of bacterial sample (containing E. coli or S. aureus) was incubated with 100 μL of either COOH–MBs–aptamers or SA–MBs–aptamers at 25 °C for 2 h with gentle agitation. Magnetic separation (0.3 T for 10 s) was then used to isolate the bead-bound bacteria. After washing with deionized water to remove non-specifically bound bacteria, DNase I (1 unit/μL) was added to release the magnetically enriched bacteria from the aptamers. Following a 10-min incubation, the released bacteria were used for subsequent detection via azide-functionalized coverslip-mediated click chemistry with alkyne-modified gold nanorods (AuNRs).
2.8. Detection of viable bacteria from human plasma
Human plasma from a healthy volunteer was spiked with E. coli to achieve final concentrations of approximately 0, 250, 500, 1000, and 2000 cells per 30 μL. Streptavidin-modified magnetic beads conjugated with biotinylated aptamers (SA–MBs–aptamers) were then added to capture and magnetically separate the E. coli. DNase I treatment released the enriched bacteria, which were subsequently quantified using the AuNRs-based click chemistry method in the presence of CuII.
2.9. Bacteria-instructed single nanoparticle click assay for drug resistance
Antibiotic susceptibility testing (AST) was performed by incubating E. coli (108 cells) with meropenem, ceftriaxone, tetracycline, and levofloxacin at concentrations of 0.01, 0.1, and 1 mg/mL for 0, 1, 2, 4, 6, and 8 h. Following incubation, bacterial cells were harvested by centrifugation (7000 g, 3 min) and washed twice with deionized water. The resulting E. coli were then quantified using both a bacteria-instructed single-nanoparticle click assay and a standard bacterial culture method.
2.10. Analysis of drug sensitivity of different bacteria
E. coli ATCC 25922 and E. coli expressing KPC-2 (5000 cells each) were co-incubated with meropenem, ceftriaxone, tetracycline, and levofloxacin (0.01, 0.1, and 1 mg/mL) for 90 min. Antibiotic susceptibility was then determined using both AuNRs-BICC and standard culture methods.
2.11. Utilizing dark-field microscopic imaging and analyzing data
Image acquisition: all dark-field images were captured using a Leica DMi8C/HRS-300 dark-field microspectroscopy imaging system equipped with a true-color CCD sensor. Consistent imaging conditions were maintained for all reaction systems throughout the experiments. Images of ultrapure water were used as a reference background. Image selection and analysis: eight images were acquired for each sample, taken from distinct positions near the center of the reaction well. Data analysis was performed using ImageJ software (version 1.45). A central area measuring 300 × 300 μm within each image was selected for counting AuNRs. The 'analyze particles' function was used to count AuNRs within a particle size range of 2–12 pixels. Quantification: the number of AuNRs was calculated using Equation (1).:
| (1) |
where represents the net counts of AuNRs, signifies the adjusted count of AuNRs in the absence of bacteria, and corresponds to the count of AuNRs with the involvement of bacteria.
2.12. Ethics statement
Ethical approval for this study was obtained from the Ethics Committee at Zhongshan Hospital Affiliated to Fudan University (B2022-044R, approved February 25, 2022). E. coli expressing Klebsiella pneumoniae carbapenemase 2 (E. coli expressing KPC-2) were obtained from previously collected and anonymized routine microbiological specimens, no patients were directly involved in this study.
3. Result and discussion
3.1. Preparation and characterization of alkyne–modified AuNRs and azide–functionalized coverslip
Anisotropic gold nanorods (AuNRs), acting as one-dimensional nanomaterials, exhibit polarization-dependent colorful dark-field scattering [42]. In typical experiments, individual AuNRs (CTAB-modified or citrate-modified AuNRs) were selected as the imaging probes for DFM. The alkyne and thiol-modified DNA oligonucleotide strands first hybridized with the complementary strands to form a rigid double-stranded structure (dsDNA), which was subsequently assembled on the surface of AuNRs by the formation of Au–S bonds (Fig. 1A, Fig. S1A; DNA sequences are shown in Table S2). For alkyne–modified CTAB-modified AuNRs, the transmission electron microscopy (TEM) images are shown in Fig. S1B. The prepared alkyne–modified AuNPs had a homogeneous rod-like structure with a long diameter of 80 nm and a short diameter of 20 nm (Fig. S1C). Likewise, alkyne-functionalized citrate-modified AuNRs have a long diameter of 90 nm and a short diameter of 22 nm (Fig. 1B and C). The modification process of alkyne–modified AuNRs by dsDNA could first be monitored by changing the zeta potentials of AuNRs (Figs. S3 and 1E). The zeta potential of the CTAB-modified AuNRs shifted from to following the modification of alkyne–dsDNA (Fig. S3), suggesting that the CTAB ligand was successfully replaced by alkyne–dsDNA and partially neutralized some of the positive charges. For the sodium citrate-modified AuNRs, the zeta potential exhibited negligible changes before and after the modification with alkyne–dsDNA (Fig. 1E), which could be attributed to the negative charges carried by both citrate and double-stranded DNA. Moreover, the modification of alkyne–modified AuNRs by dsDNA could be easily monitored by the red-shifted surface plasmon resonance absorption peaks (Fig. 1F and S4) and the increased hydrodynamic sizes (Fig. 1G and S5).
Fig. 1.
Alkyne-functionalized gold nanorods (AuNRs) were characterized as follows: (A) A schematic illustrates citrate-modified AuNRs before and after alkyne-DNA conjugation. (B) and (C) Transmission electron microscopy (TEM) images and size distributions (long and short axes) of citrate-modified AuNRs. (D) DFM images depict AuNRs following the addition of sodium ascorbate (NaAsc, 100 μM), CuII (10 μM), and alkyne-functionalized AuNRs to azide-functionalized coverslips. (E) Zeta potential distributions are presented for citrate-modified AuNRs before and after alkyne-DNA modification. (F) UV–vis absorbance spectra of citrate-modified AuNRs before and after alkyne-DNA modification. (G) Hydration radius distributions of citrate-capped AuNRs before and after alkyne-DNA modification. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Passivation and modification of the coverslip surface utilizing PLL–PEG–azide was conducted with a slight modification based on previous methods [41]. In brief, the sample cells underwent an initial etching process using vacuum plasma, followed by co-incubation with PLL–PEG and PLL–PEG–azide. To confirm the successful alkyne functionalization of the coverslips, we utilized click chemistry to assess the CuI-catalyzed conjugation between azide-functionalized coverslip and AuNRs functionalized with the terminal alkyne. In the presence of ascorbate sodium, the catalyst (CuI) was conveniently derived from the reduction of CuII. The generation of scattered signals from AuNRs was observed via DFM (Fig. 1D and S2). However, the CuAAC reaction could not occur when only the PLL–PEG modification was applied to the coverslip slides. Subsequently, no significant scattering signal of individual plasmonic nanoparticles was observed via DFM (Fig. S6).
3.2. Principle of the AuNRs–BICC method for POC microbial detection
Copper, a redox-active transition metal, is crucial for aerobic metabolism, necessitating tight control of intracellular copper homeostasis. Under anaerobic conditions, copper undergoes a transition from the CuII to the CuI oxidation state. Consequently, intracellular copper concentrations are maintained within very narrow physiological limits [[43], [44], [45]]. This is primarily due to the ability of CuI to readily diffuse across the cytoplasmic membrane, facilitating its role as a selective catalyst for alkyne-azide cycloaddition reactions. Initially, we conceived and fabricated a micro-upgrade (30 μL) sterile and closed microreactor conjugated by one azide-functionalized coverslip with two punched Flexdym chips. In the presence of bacteria, CuII can be reduced to CuI by autologous copper-binding and the pathway (Fig. 2A), which results in the attachment of alkyne-functionalized AuNRs to the sensing interfaces (azide–functionalized coverslip) via a CuI-catalyzed azide–alkyne cycloaddition (CuAAC) reaction [[46], [47],[45], [46]]. In the presence of bacteria, the number of bacteria was estimated by counting the quantity of AuNRs attached to the sensing interface via the CuAAC reaction via DFM (Fig. 2C). The CuAAC reaction could not occur in the absence of bacteria and was used as the control. No observable counts of AuNRs were detected via DFM (Fig. 2B). Following the interaction of antibiotics with bacteria, the bacterial activity was inhibited, resulting in a diminished reduction ability of CuII to CuI. This reduction in reactivity diminished the efficiency of the CuAAC reaction, ultimately leading to a decrease in the count of AuNRs observed via DFM (Fig. 2D). Consequently, this sensor is expected to function as an indicator of bacterial viability and serve as a valuable tool for drug screening.
3.3. Bacteria-instructed click chemistry between the azide–functionalized coverslip and alkyne–modified AuNRs
To investigate the feasibility of bacteria-instructed click chemistry of individual AuNRs on the azide–functionalized coverslip, a model bacterium, E. coli, with a concentration of 107 colony-forming units, was introduced into the microreactor and mixed with alkyne–modified AuNRs in the presence of CuII on the azide–functionalized coverslip. As expected, as shown in Fig. 3D and H, the occurrence of bright scattered signals in DFM necessitates the simultaneous presence of the azide–functionalized coverslip, alkyne–modified AuNRs, and CuII following 2 h of incubation with live E. coli. Indeed, as a control, the other groups (without live E. coli, without CuII, or without live E. coli and CuII) did not show any significant dark-field scattered signals in DFM (Fig. 3A–C, 3E–3G), which was attributed to the gold nanoparticles not participating in the CuI-catalyzed click chemistry reaction and not forming covalent bonds with the substrate. In addition, bacteria were inactivated by heating at 80 °C for 10 min, ensuring complete loss of viability while maintaining structural integrity. We found the dead bacteria could not catalyze the conversion of CuII to CuI in situ. Thus, the scattered signals from plasmonic nanoparticles attached to the coverslip slide could not be monitored under DFM (Fig. 3I and J). Interestingly, there was a noticeable distinction in the scattered signals observed via DFM for the bacterial-instructed click chemistry reaction involving two kinds of AuNRs. For the citrate–modified AuNRs, the typical scattered signal of AuNRs was observed via DFM (Fig. 3D). In the case of CTAB–modified AuNRs, the scattered signal exhibited an elongated shape resembling that of E. coli, and these signals did not originate from the plasmonic nanorods upon DFM (Fig. 3H). In contrast, when only CTAB–modified AuNRs or E. coli was present, there was no noticeable scattered signal (Fig. S7). However, upon mixing E. coli with CTAB–modified AuNRs, a significantly enhanced intensity and area magnification of the scattered signal counts were observed (Fig. 3H, Fig. S8). This enhancement may result from electrostatic interactions, with positively charged CTAB–modified AuNRs adhering to the negatively charged bacterial surface, significantly enhancing the scattered signal from the bacteria (as illustrated in Fig. S9). Therefore, we utilized negatively charged citrate–modified AuNRs in subsequent experiments as single-particle dark-field imaging probes.
Fig. 3.
DFM images were acquired under various conditions. For citrate-modified AuNRs: (A) AuNRs only; (B) AuNRs without CuII; (C) AuNRs without live E. coli; (D) AuNRs with CuII and live E. coli; (I) AuNRs with CuII and dead E. coli. For CTAB-modified AuNRs: (E) AuNRs only; (F) AuNRs without CuII; (G) AuNRs without live E. coli; (H) AuNRs with CuII and live E. coli; (J) AuNRs with CuII and dead E. coli.
3.4. Sensing performance of the AuNRs–BICC method for the quantification of bacteria
To examine the sensing performance of the single-particle counting strategy based on CuI-catalyzed click chemistry for bacteria quantification, we added different quantities of bacteria into the microreactor (azide–functionalized coverslip, 1 mg/mL alkyne–AuNRs, 10 μM of CuII, 2 h of bacterial reaction time) to count the AuNRs attached to the sensing interface. The average counts of AuNRs in the eight regions were extracted for enumeration to minimize measurement errors. Fig. 4A shows the DFM images of AuNRs in the presence of different quantities of E. coil (0 to 107 cells). As the quantities of E. coli increased, the counts of AuNRs also increased rapidly, tending to reach saturation upon further increasing the quantities of E. coli beyond 107 cells (Fig. 4B). In the range of E. coli from 101 to 107 cells, the counts of AuNRs and the logarithm of the quantities of E. coli showed a good linear relationship. As shown in the inset of Fig. 4B, the linear regression equation is , (), where is the net counts of AuNRs, and is the number of bacteria. Furthermore, we confirmed the versatility of the single-particle counting strategy with two other types of bacteria: gram-positive S. aureus and antibiotic-resistant E. coli strains (E. coli expressing KPC-2). As depicted in Fig. 3C and D, we also obtained the linear calibration curves for S. aureus (, ) and E. coli expressing KPC-2 (, ) relating the net counts of AuNRs to the number of bacteria from 101 to 107 cells. The differences in slope observed in the linear calibration curves obtained for various pathogenic bacteria may be attributed to their distinct capacities for reducing CuII [14,24,[45], [46]]. The limit of detection (LOD) values were defined as the minimum observable bacterial concentration that could be reliably detected under the experimental conditions. And this AuNRs–BICC method exhibited sensitivity down to 101 cells for the quantitative detection of bacteria while maintaining an extended linear range from 101 to 107 cells, along with a simplified optical imaging setup. This may be explained by the controllable fixation of PLL–PEG–azide on the surface of the coverslip, the high efficiency of bacteria in reducing CuII to CuI [47,48], the specificity and high efficiency of the CuI-catalyzed azide–functionalized coverslip and the alkyne–modified AuNRs cycloaddition promoted by ring strain, and the low background of DFM.
Fig. 4.
Bacteria assay sensitivity: (A) DFM images of the AuNRs corresponding to 0, 101, 102, 103, 104, 105, 106, and 107 cells of E. coil. (B) Graph of the counts of AuNR changes with different quantities of E. coli from 101 to 108 cells. The inset shows the linear relationship between the AuNR counts and the logarithm value of the number of E. coli. The graphs in (C) and (D) display the variation in the counts of AuNRs as they change with different quantities of S. aureus and E. coli expressing KPC-2, respectively, showing a linear relationship in each inset.
3.5. Portable platform for detecting bacteria in complicated sepsis blood samples
Beyond general bacterial detection, the ability to selectively identify and quantify specific bacterial strains within complex real-world samples holds significant clinical importance [49]. To detect one specific bacterial strain coexisting with other strains, we first constructed one aptamer-assisted bacterial capturer and then quantified the number of bacteria using the AuNRs–BICC method. This bacterial separation system is based on Fe3O4 magnetic nanoparticles modified with bacterial species-identifiable aptamers to realize separation and enrichment of specific bacterial strains from a blood sample (the sequences of oligonucleotides for E. coil and S. aureus provided in Table S2, Fig. S10, and Fig. S11). As demonstrated in Fig. 5A, the concentrated bacteria were released from magnetic nanoparticles via treatment with DNase 1 following magnetic separation. The released bacteria reduced CuII to CuI, subsequently catalyzing the CuAAC reaction. Quantitative determination of bacteria can be achieved by counting the AuNRs using DFM. As illustrated in Fig. 5B, when E. coli was captured using SA–MBs coupled with the 3′-biotin–E. coli aptamer, the capture efficiency exceeded 50 % (E. coli cells ranging from 101 to 103) within 30 min. However, when carboxyl-functionalized magnetic beads were covalently modified with amino-functionalized aptamers, the efficiency of capturing E. coli was only 20 % (Fig. S12). We speculate that the higher capture efficiency is partly attributed to the stronger affinity between biotin and streptavidin (Kd ≈ 10−14 M) [50]. Additionally, the binding of biotin and streptavidin on the surface of the magnetic beads provides the oligonucleotides with greater stretching space, which is more conducive to capturing bacteria. Similarly, when the surface of SA–MBs was modified with S. aureus-specific aptamers, the efficiency of capturing S. aureus approached 60 % (Fig. S13).
Fig. 5.
(A) Schematic illustration of magnetic capture and separation by Fe3O4 magnetic nanoparticles modified with bacterial species-identifiable aptamers from the blood sample and enzymolysis by DNase 1. (B) Capture efficiency of SA–MBs coupled with the 3′-biotin–E. coli aptamer toward E. coli bacteria with concentrations ranging from 101, 102, and 103 cells after 30 min of incubation. (C) Agar plate cultivation images and AuNRs–BICC images of the same quantity of bacteria obtained upon magnetic separation and DNase-triggered release. (D) Linear correlation analysis between the determined number of bacteria in the blood sample using the AuNRs–BICC method and agar plate cultivation.
After magnetic separation and DNase-triggered release, the concentrated E. coli obtained from the complex sepsis blood samples was mixed with alkyne–modified AuNRs and CuII and then introduced into the microreactor. To validate the feasibility of our method, we compared the results obtained from the AuNRs–BICC method with the culture method using E. coli as the model. Equivalent bacteria obtained via magnetic separation and DNase-triggered release were divided into two parts. One was plated onto agar plates for cultivation, while another was introduced into the click chemistry reactor (Fig. 5C). As shown in Fig. 5D, the number of bacteria measured using the AuNRs–BICC method closely matches the number obtained from the culture method. Compared to prolonged bacterial agar plate cultivation (>24 h), the entire process of bacterial magnetic enrichment and separation, release triggered by DNase 1, and single-particle enumeration can be accomplished in 3 h, meeting the time constraints of clinical POC sensing.
3.6. Evaluation of bacterial AST using single-particle click chemistry
Antibiotic susceptibility testing (AST) of E. coli was performed using the AuNRs-BICC method to assess the impact of various antibiotics on bacterial viability. Antibiotic susceptibility testing (AST) was performed using four antibiotics with distinct mechanisms of action: meropenem, ceftriaxone, tetracycline, and levofloxacin. Meropenem and ceftriaxone are β-lactam antibiotics that inhibit bacterial cell wall synthesis. Tetracycline, a tetracycline antibiotic, inhibits protein synthesis. Levofloxacin, a fluoroquinolone antibiotic, inhibits DNA replication and transcription. Bacterial suspensions (108 cells) were incubated with the antibiotics at different concentrations (0.01, 0.1, and 1 mg/mL) for different periods and then mixed with alkyne–modified AuNRs and CuII onto the azide–functionalized coverslip in a microreactor for AuNRs–BICC detection. As depicted in Fig. 6, the AST responses of E. coli to different antibiotics varied. In the presence of β-lactam antibiotics, E. coli viability decreased sharply, with meropenem exhibiting the strongest inhibitory effect across all three concentrations (Fig. 6A and B). At a concentration of 0.01 mg/mL, tetracycline displayed mild inhibitory effects (Fig. 6C), while levofloxacin, even at three different concentrations, failed to completely deactivate all bacterial cells after 8 h of incubation (Fig. 6D). Additionally, we confirmed the reliability of these results using the bacterial culture method. As shown in Fig. S14, the bactericidal effects of meropenem, ceftriaxone, and tetracycline measured by the bacterial culture method were consistent with those observed using the AuNRs–BICC method.
Fig. 6.
AST responses of E. coli (108 CFU/mL) to different antibiotics for different periods: (A) meropenem, (B) ceftriaxone, (C) tetracycline, and (D) levofloxacin, assayed by the AuNRs–BICC method. The antibiotic concentrations were 0.01, 0.1, and 1 mg/mL, with error bars representing the standard deviation (n = 3). AST responses of (E) E. coli (ATCC 25922) (5000 cells) and (F) E. coli expressing KPC-2 (5000 cells) when bacteria were co-cultured with four antibiotics for 90 min.
Unexpectedly, the AST results for E. coli exposed to levofloxacin, as determined by the AuNRs–BICC method, differed from those obtained using the bacterial culture method. The results from the bacterial culture method indicated that levofloxacin at high concentrations effectively inhibited bacterial growth. In contrast, the AuNRs–BICC method showed that even at the highest concentration of levofloxacin, the rates of click chemistry reactions did not decrease significantly. Similar findings were reported by Mason et al. [51], in which observed that the bacteria remained viable but entered a non-proliferative state after incubation with high concentrations of quinolone antibiotics, continuously reducing CuII to CuI. Therefore, we did not observe a reduction in the counts of AuNRs, even at high concentrations of levofloxacin. This is a limitation of the AuNRs–BICC method is that it is not suitable for screening quinolone antibiotics.
We also conducted AST on two bacterial strains, drug-sensitive E. coli and E. coli expressing KPC-2, exposed to three antibiotics (meropenem, ceftriaxone, and tetracycline). As illustrated in Fig. 6E, the activity of E. coli was inhibited by the antibiotics, resulting in a decrease in the counts of AuNRs detected by the AuNRs–BICC method. In contrast, E. coli expressing KPC-2, as one carbapenem-resistant Enterobacteriaceae (CRE), displayed resistance to all three antibiotics, and consequently, the counts of AuNRs detected by the AuNRs–BICC method remained relatively unchanged (Fig. 6F). As expected, the results obtained from the AuNRs–BICC method were consistent with the results obtained from the bacterial culture method (Fig. S15).
4. Conclusion
In summary, this work presents a novel microbial sensor (AuNRs–BICC) based on citrate- and alkyne-modified gold nanorods (AuNRs) with click chemistry properties and exceptional biocompatibility. These AuNRs enable a unique approach for bacterial quantification, viability assessment, and antimicrobial susceptibility testing. The sensor harnesses the bacterial metabolic process for CuII binding and reduction, triggering a click chemistry reaction between azide-functionalized coverslip surfaces and alkyne-modified AuNRs. This reaction is visualized through dark-field microscopy imaging and analyzed via single-particle enumeration with bacteria-initiated click chemistry. The AuNRs–BICC sensor offers several advantages: (i) high efficiency and excellent biocompatibility, (ii) a clean imaging background without nonspecific scattering signals, (iii) simplicity and portability in detection and preparation, and (iv) rapid (within 3 h) and sensitive bacterial quantification (down to 101 cells), viability assessment, and antimicrobial susceptibility testing. Compared to traditional methods, this AuNRs–BICC sensor shows great potential for clinical point-of-care (POC) diagnosis of bacterial infections, evaluating the effectiveness of antibacterial drugs, and helping to reduce the occurrence of bacterial resistance.
CRediT authorship contribution statement
Tongtong Tian: Writing – original draft, Visualization, Project administration, Methodology, Funding acquisition, Conceptualization. Wenjing Yang: Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Xiaohuan Wang: Methodology, Investigation, Formal analysis, Data curation. Te Liu: Investigation, Formal analysis, Data curation. Baishen Pan: Investigation, Formal analysis, Data curation. Wei Guo: Writing – review & editing, Validation, Funding acquisition. Beili Wang: Writing – review & editing, Validation, Supervision, Resources.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (Grant No. 82202636, 82172348), Shanghai Sailing Program, China (Grant No. 22YF1406300). The constructing project of clinical key disciplines in Shanghai, China (Grant No. shslczdzk03302). Baoshan District Health Commission Key Subject Construction Project, China (Grant No. BSZK-2023-A18). The key medical and health projects of Xiamen, China (Grant No. YDZX20193502000002).
Footnotes
This article is part of a special issue entitled: Biomarker published in Materials Today Bio.
Supplementary data to this article can be found online at https://doi.org/10.1016/j.mtbio.2025.101453.
Contributor Information
Wei Guo, Email: guo.wei@zs-hospital.sh.cn.
Beili Wang, Email: wang.beili1@zs-hospital.sh.cn.
Appendix B. Supplementary data
The following is the Supplementary data to this article:
Data availability
No data was used for the research described in the article.
References
- 1.Murray C.J.L., Ikuta K.S., Sharara F., Swetschinski L., Aguilar G.R., Gray A., Han C., Bisignano C., Rao P., Wool E., Johnson S.C., Browne A.J., Chipeta M.G., Fell F., Hackett S., Haines-Woodhouse G., Hamadani B.H.K., Kumaran E.A.P., McManigal B., Agarwal R., Akech S., Albertson S., Amuasi J., Andrews J., Aravkin A., Ashley E., Bailey F., Baker S., Basnyat B., Bekker A., Bender R., Bethou A., Bielicki J., Boonkasidecha S., Bukosia J., Carvalheiro C., Castañeda-Orjuela C., Chansamouth V., Chaurasia S., Chiurchiù S., Chowdhury F., Cook A.J., Cooper B., Cressey T.R., Criollo-Mora E., Cunningham M., Darboe S., Day N.P.J., Luca M.D., Dokova K., Dramowski A., Dunachie S.J., Eckmanns T., Eibach D., Emami A., Feasey N., Fisher-Pearson N., Forrest K., Garrett D., Gastmeier P., Giref A.Z., Greer R.C., Gupta V., Haller S., Haselbeck A., Hay S.I., Holm M., Hopkins S., Iregbu K.C., Jacobs J., Jarovsky D., Javanmardi F., Khorana M., Kissoon N., Kobeissi E., Kostyanev T., Krapp F., Krumkamp R., Kumar A., Kyu H.H., Lim C., Limmathurotsakul D., Loftus M.J., Lunn M., Ma J., Mturi N., Munera-Huertas T., Musicha P., Mussi-Pinhata M.M., Nakamura T., Nanavati R., Nangia S., Newton P., Ngoun C., Novotney A., Nwakanma D., Obiero C.W., Olivas-Martinez A., Olliaro P., Ooko E., Ortiz-Brizuela E., Peleg A.Y., Perrone C., Plakkal N., Ponce-de-Leon A., Raad M., Ramdin T., Riddell A., Roberts T., Robotham J.V., Roca A., Rudd K.E., Russell N., Schnall J., Scott J.A.G., Shivamallappa M., Sifuentes-Osornio J., Steenkeste N., Stewardson A.J., Stoeva T., Tasak N., Thaiprakong A., Thwaites G., Turner C., Turner P., Doorn H.R., Velaphi S., Vongpradith A., Vu H., Walsh T., Waner S., Wangrangsimakul T., Wozniak T., Zheng P., Sartorius B., Lopez A.D., Stergachis A., Moore C., Dolecek C., Naghavi M. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–655. doi: 10.1016/S0140-6736(21)02724-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Larsson D.G.J., Flach C.-F. Antibiotic resistance in the environment. Nat. Rev. Microbiol. 2022;20:257–269. doi: 10.1038/s41579-021-00649-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Broom A., Peterie M., Kenny K., Broom J., Kelly-Hanku A., Lafferty L., Treloar C., Applegate T. Vulnerability and antimicrobial resistance, Crit. Publ. Health. 2023;33:308–317. [Google Scholar]
- 4.Vihta K.D., Stoesser N., Llewelyn M.J., Quan T.P., Davies T., Fawcett N.J., Dunn L., Jeffery K., Butler C.C., Hayward G., Andersson M., Morgan M., Oakley S., Mason A., Hopkins S., Wyllie D.H., Crook D.W., Wilcox M.H., Johnson A.P., Peto T.E.A., Walker A.S. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records. Lancet Infect. Dis. 2018;18:1138–1149. doi: 10.1016/S1473-3099(18)30353-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.van Belkum A., Bachmann T.T., Ludke G., Lisby J.G., Kahlmeter G., Mohess A., Becker K., Hays J.P., Woodford N., Mitsakakis K., Moran-Gilad J., Vila J., Peter H., Rex J.H., Jr Dunne W.M., Grp J.A.-R.W. Developmental roadmap for antimicrobial susceptibility testing systems. Nat. Rev. Microbiol. 2019;17:51–62. doi: 10.1038/s41579-018-0098-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Belgrader P., Benett W., Hadley D., Richards J., Stratton P., Jr Mariella R., Milanovich F. PCR detection of bacteria in seven min. Science. 1999;284:449–450. doi: 10.1126/science.284.5413.449. [DOI] [PubMed] [Google Scholar]
- 7.Geertsema H.J., Schulte A.C., Spenkelink L.M., McGrath W.J., Morrone S.R., Sohn J., Mangel W.F., Robinson A., van Oijen A.M. Single-molecule imaging at high fluorophore concentrations by local activation of dye. Biophys. J. 2015;108:949–956. doi: 10.1016/j.bpj.2014.12.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Jiao C., Duan W., Wu X., Shang Y., Zhang F., Zhang M., Chen X., Zeng J., Yang C. Multifunctional nanoprobe-amplified enzyme-linked immunosorbent assay on capillary: a universal platform for simple, rapid, and ultrasensitive dual-mode pathogen detection. Anal. Chem. 2023;95:11316–11325. doi: 10.1021/acs.analchem.3c01375. [DOI] [PubMed] [Google Scholar]
- 9.Lin X., Zhao M., Peng T., Zhang P., Shen R., Jia Y. Detection and discrimination of pathogenic bacteria with nanomaterials-based optical biosensors: a review. Food Chem. 2023;426 doi: 10.1016/j.foodchem.2023.136578. [DOI] [PubMed] [Google Scholar]
- 10.Wu E., Yi J., Liu B., Qiao L. Assessment of bacterial viability by laser desorption ionization mass spectrometry for antimicrobial susceptibility testing. Talanta. 2021;233 doi: 10.1016/j.talanta.2021.122535. [DOI] [PubMed] [Google Scholar]
- 11.Fu X., Sun J., Ye Y., Zhang Y., Sun X. A rapid and ultrasensitive dual detection platform based on Cas12a for simultaneous detection of virulence and resistance genes of drug-resistant Salmonella. Biosens. Bioelectron. 2022;195 doi: 10.1016/j.bios.2021.113682. [DOI] [PubMed] [Google Scholar]
- 12.Ma Y., Zhang Y., Gao J., Ouyang H., He Y., Fu Z. PEGylated Ni single-atom catalysts as ultrasensitive electrochemiluminescent probes with favorable aqueous dispersibility for assaying drug-resistant pathogens. Anal. Chem. 2022;94:14047–14053. doi: 10.1021/acs.analchem.2c03546. [DOI] [PubMed] [Google Scholar]
- 13.Song Y., Park N., Jo D.A., Kim J., Yong D., Song J., Park Y.M., Lee S.J., Kim Y.T., Im S.G., Choi B.G., Kang T., Lee K.G. Polyaniline-based 3D network structure promotes entrapment and detection of drug-resistant bacteria. Nano Converg. 2023;10:25. doi: 10.1186/s40580-023-00370-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Mou X.Z., Chen X.Y., Wang J., Zhang Z., Yang Y., Shou Z.X., Tu Y.X., Du X., Wu C., Zhao Y., Qiu L., Jiang P., Chen C., Huang D.S., Li Y.Q. Bacteria-instructed click chemistry between functionalized gold nanoparticles for point-of-care microbial detection. ACS Appl. Mater. Interfaces. 2019;11:23093–23101. doi: 10.1021/acsami.9b09279. [DOI] [PubMed] [Google Scholar]
- 15.Rensing C., Grass G. Escherichia coli mechanisms of copper homeostasis in a changing environment. FEMS Microbiol. Rev. 2003;27:197–213. doi: 10.1016/S0168-6445(03)00049-4. [DOI] [PubMed] [Google Scholar]
- 16.Price E.E., Boyd J.M. Genetic regulation of metal ion homeostasis in Staphylococcus aureus. Trends Microbiol. 2020;28:821–831. doi: 10.1016/j.tim.2020.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Pontel L.B., Soncini F.C. Alternative periplasmic copper-resistance mechanisms in gram negative bacteria. Mol. Microbiol. 2009;73:212–225. doi: 10.1111/j.1365-2958.2009.06763.x. [DOI] [PubMed] [Google Scholar]
- 18.Wei H., Bu S., Zhang W., Ma L., Liu X., Wang Z., Li Z., Hao Z., He X., Wan J. An electrochemical biosensor for the detection of pathogenic bacteria based on dual signal amplification of Cu3(PO4)2-mediated click chemistry and DNAzymes. Analyst. 2021;146:4841–4847. doi: 10.1039/d1an00982f. [DOI] [PubMed] [Google Scholar]
- 19.Tarnowska M., Krawczyk T. Click chemistry as a tool in biosensing systems for sensitive copper detection. Biosens. Bioelectron. 2020;169:112614–112628. doi: 10.1016/j.bios.2020.112614. [DOI] [PubMed] [Google Scholar]
- 20.Nguyen H.A., Lee N.Y. Polydopamine aggregation: a novel strategy for power-free readout of loop-mediated isothermal amplification integrated into a paper device for multiplex pathogens detection. Biosens. Bioelectron. 2021;189:113353–113362. doi: 10.1016/j.bios.2021.113353. [DOI] [PubMed] [Google Scholar]
- 21.Li W., Cai Y., Yang Y., Miao J., Xu Y. Novel electrochemical nuclear factorkappa B biosensor via analyte-restrained peptide nucleic acid displacement reaction constructed on different gold nanoparticle-deposited carbon electrodes. Sensor. Actuator. B Chem. 2021;335:129702–129709. [Google Scholar]
- 22.Ciftci S., Cánovas R., Neumann F., Paulraj T., Nilsson M., Crespo G.A., Madaboosi N. The sweet detection of rolling circle amplification: glucose-based electrochemical genosensor for the detection of viral nucleic acid. Biosens. Bioelectron. 2020;151:112002–112010. doi: 10.1016/j.bios.2019.112002. [DOI] [PubMed] [Google Scholar]
- 23.Peng X., Yan H., Wu Z., Wen W., Zhang X., Wang S. Magnetic nanobeads and de novo growth of electroactive polymers for ultrasensitive microRNA detection at the cellular level. Anal. Chem. 2021;93:902–910. doi: 10.1021/acs.analchem.0c03558. [DOI] [PubMed] [Google Scholar]
- 24.Li Y., Li W., Yang Y., Bao F., Lu J., Miao J., Xu Y. A universal biosensor utilizing bacteria-initiated in situ growth of electroactive polymers for bacteria-related hazards detection. Biosens. Bioelectron. 2022;203 doi: 10.1016/j.bios.2022.114030. [DOI] [PubMed] [Google Scholar]
- 25.Hu Q., Wang Q., Kong J., Li L., Zhang X. Electrochemically mediated in situ growth of electroactive polymers for highly sensitive detection of double-stranded DNA without sequence-preference. Biosens. Bioelectron. 2018;101:1–6. doi: 10.1016/j.bios.2017.09.045. [DOI] [PubMed] [Google Scholar]
- 26.Hu Q., Gan S., Bao Y., Zhang Y., Han D., Niu L. Electrochemically controlled ATRP for cleavage-based electrochemical detection of the prostate-specific antigen at femtomolar level concentrations. Anal. Chem. 2020;92:15982–15988. doi: 10.1021/acs.analchem.0c03467. [DOI] [PubMed] [Google Scholar]
- 27.Mosquera J., Wang D., Bals S., Liz-Marzán L.M. Surfactant layers on gold nanorods. Acc. Chem. Res. 2023;56:1204–1212. doi: 10.1021/acs.accounts.3c00101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Peng H.L., Zhang Y., Liu H., Gao C. Flexible wearable electrochemical sensors based on AuNR/PEDOT:PSS for simultaneous monitoring of levodopa and uric acid in sweat. ACS Sens. 2024;9:3296–3306. doi: 10.1021/acssensors.4c00649. [DOI] [PubMed] [Google Scholar]
- 29.Zhang J., Guo B., Jiang Y., Hu C., Kim J., Debnath S., Shi X., Zhang C., Kim J.S., Wang F. Luciferase-decorated gold nanorods as dual-modal contrast agents for tumor-targeted high-performance bioluminescence/photoacoustic imaging. Anal. Chem. 2024 Jun 4;96(22):9132–9140. doi: 10.1021/acs.analchem.4c00817. [DOI] [PubMed] [Google Scholar]
- 30.Tian L., Su M., Yu F., Xu Y., Li X., Li L., Liu H., Tan W. Liquid-state quantitative SERS analyzer on self-ordered metal liquid-like plasmonic arrays. Nat. Commun. 2018;9:3642. doi: 10.1038/s41467-018-05920-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sun I.C., Dumani D.S., Emelianov S.Y. Applications of the photocatalytic and photoacoustic properties of gold nanorods in contrast-enhanced ultrasound and photoacoustic imaging. ACS Nano. 2024;18:3575–3582. doi: 10.1021/acsnano.3c11223. [DOI] [PubMed] [Google Scholar]
- 32.Xiao L., Wei L., He Y., Yeung E.S. Single molecule biosensing using color coded plasmon resonant metal nanoparticles. Anal. Chem. 2010;82:6308–6314. doi: 10.1021/ac101018v. [DOI] [PubMed] [Google Scholar]
- 33.Tian T., Zhao J., Wang Y., Li B., Qiao L., Zhang K., Liu B. Transpeptidation-mediated single-particle imaging assay for sensitive and specific detection of sortase with dark-field optical microscopy. Biosens. Bioelectron. 2021;178 doi: 10.1016/j.bios.2021.113003. [DOI] [PubMed] [Google Scholar]
- 34.Tian T., Yao Y., Yang B., Zhang K., Liu B. Ultrasensitive amplification-free detection of protein kinase based on catalyzed assembly and enumeration of gold nanoparticles. Chem. Commun. 2019;55:2505–2508. doi: 10.1039/c9cc00131j. [DOI] [PubMed] [Google Scholar]
- 35.Heyes C.D., Groll J., Moller M., Nienhaus G.U. Synthesis, patterning and applications of star-shaped poly(ethylene glycol) biofunctionalized surfaces. Mol. Biosyst. 2007;3:419–430. doi: 10.1039/b700055n. [DOI] [PubMed] [Google Scholar]
- 36.Revyakin A., Zhang Z., Coleman R.A., Li Y., Inouye C., Lucas J.K., Park S.-R., Chu S., Tjian R. Transcription initiation by human RNA polymerase II visualized at single-molecule resolution. Genes Dev. 2012;26:1691–1702. doi: 10.1101/gad.194936.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Elting M.W., Leslie S.R., Churchman L.S., Korlach J., McFaul C.M.J., Leith J.S., Levene M.J., Cohen A.E., Spudich J.A. Single-molecule fluorescence imaging of processive myosin with enhanced background suppression using linear zero-mode waveguides (ZMWs) and convex lens induced confinement (CLIC) Opt Express. 2013;21:1189–1202. doi: 10.1364/OE.21.001189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Zhao Y., Li Y., Zhang P., Yan Z., Zhou Y., Du Y., Qu C., Song Y., Zhou D., Qu S., Yang R. Cell-based fluorescent microsphere incorporated with carbon dots as a sensitive immunosensor for the rapid detection of Escherichia coli O157 in milk. Biosens. Bioelectron. 2021;179:113057–113064. doi: 10.1016/j.bios.2021.113057. [DOI] [PubMed] [Google Scholar]
- 39.Sau T.K., Murphy C.J. Seeded high yield synthesis of short Au nanorods in aqueous solution. Langmuir. 2004;20:6414–6420. doi: 10.1021/la049463z. [DOI] [PubMed] [Google Scholar]
- 40.Mehtala J.G., Zemlyanov D.Y., Max J.P., Kadasala N., Zhao S., Wei A. Citrate-stabilized gold nanorods. Langmuir. 2014;30:13727–13730. doi: 10.1021/la5029542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Zhao M., Nicovich P.R., Janco M., Deng Q., Yang Z., Ma Y., Böcking T., Gaus K., Gooding J.J. Ultralow- and low-background surfaces for single-molecule localization microscopy of multistep biointerfaces for single-molecule sensing. Langmuir. 2018;34:10012–10018. doi: 10.1021/acs.langmuir.8b01487. [DOI] [PubMed] [Google Scholar]
- 42.Liu J.J., Wen S., Yan H.H., Cheng R., Zhu F., Gao P.F., Zou H.Y., Huang C.Z., Wang J. The accurate imaging of collective gold nanorods with a polarization-dependent dark-field light scattering microscope. Anal. Chem. 2023;95:1169–1175. doi: 10.1021/acs.analchem.2c03911. [DOI] [PubMed] [Google Scholar]
- 43.Lennen R.M., Pfleger B.F. Engineering Escherichia coli to synthesize free fatty acids. Trends Biotechnol. 2012;30:659–667. doi: 10.1016/j.tibtech.2012.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Zu Y., Prather K.L., Stephanopoulos G. Metabolic engineering strategies to overcome precursor limitations in isoprenoid biosynthesis. Curr. Opin. Biotechnol. 2020;66:171–178. doi: 10.1016/j.copbio.2020.07.005. [DOI] [PubMed] [Google Scholar]
- 45.Partipilo G., Graham A.J., Belardi B., Keitz B.K. Extracellular electron transfer enables cellular control of Cu(I)-catalyzed alkyne-azide cycloaddition. ACS Cent. Sci. 2022;8:246–257. doi: 10.1021/acscentsci.1c01208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Djoko K.Y., Phan M.D., Peters K.M., Walker M.J., Schembri M.A., McEwan A.G. Interplay between tolerance mechanisms to copper and acid stress in Escherichia coli. Proc. Natl. Acad. Sci. USA. 2017;114:6818–6823. doi: 10.1073/pnas.1620232114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Yan R., Shou Z., Chen J., Wu H., Zhao Y., Qiu L., Jiang P., Mou X.-Z., Wang J., Li Y.-Q. On-off-on gold nanocluster-based fluorescent probe for rapid Escherichia coli differentiation, detection and bactericide screening. ACS Sustainable Chem. Eng. 2018;6:4504–4509. [Google Scholar]
- 48.Bennett M.R., Gurnani P., Hill P.J., Alexander C., Rawson F.J. Iron-catalysed radical polymerisation by living bacteria. Angew. Chem. Int. Ed. 2020;59:4750–4755. doi: 10.1002/anie.201915084. [DOI] [PubMed] [Google Scholar]
- 49.El-Boubbou K., Gruden C., Huang X. Magnetic glyco-nanoparticles: a unique tool for rapid pathogen detection, decontamination, and strain differentiation. J. Am. Chem. Soc. 2007;129:13392–13393. doi: 10.1021/ja076086e. [DOI] [PubMed] [Google Scholar]
- 50.Udeshi N.D., Pedram K., Svinkina T., Fereshetian S., Myers S.A., Aygun O., Krug K., Clauser K., Ryan D., Ast T., Mootha V.K., Ting A.Y., Carr S.A. Antibodies to biotin enable large-scale detection of biotinylation sites on proteins. Nat. Methods. 2017;14:1167–1170. doi: 10.1038/nmeth.4465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Mason D.J., Power E.G., Talsania H., Phillips I., Gant V.A. Antibacterial action of ciprofloxacin, Antimicrob. Agents. Chemother. 1995;39:2752–2758. doi: 10.1128/aac.39.12.2752. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
No data was used for the research described in the article.







